Valuation (62%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 17.40 | N/A |
| PEG Ratio (TTM) | 0.98 | N/A |
| P/S Ratio (TTM) | 1.97 | N/A |
| P/B Ratio (TTM) | 5.20 | N/A |
| P/FCF Ratio (TTM) | 9.88 | N/A |
| Price to 5YR AVG Earnings Ratio | 39.91 | N/A |
| Price to 5YR AVG FCF Ratio | 19.06 | N/A |
Profitability (70%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 7.71% | N/A |
| ROE (TTM) | 35.04% | N/A |
| Net Profit Margin (TTM) | 11.33% | N/A |
| ROIC 5YR AVG | 20.14% | N/A |
Growth (87%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 29.41% | 17.60% | 85.83% |
| Revenue | 6.17% | 14.40% | 14.48% |
| Net Income | 29.27% | 18.08% | 83.33% |
| Cash Flow | 15.83% | 7.44% | 13.19% |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | N/A |
| Quick Ratio (TTM) | N/A | N/A |
| D/E Ratio (TTM) | 0.25 | N/A |
| Interest Coverage (TTM) | 25.13 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 2.61 | N/A |
| LTL to 5YR AVG FCF | 0.93 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.09% | N/A |